Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

4-HNE, 4-hydroxynonenal; 8-isoprostane, 8-isoprostaglandin F2α; AGE, advanced glycation end product; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CAT, catalase; CI, confidence interval; CP, chronic periodontitis; DM, diabetes mellitus; DMCP, diabetes-related periodontitis; Foxp3, forkhead box P3; G-CSF, granulocyte colony-stimulating factor; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide-1; GM-CSF, granulocyte-macrophage colony-stimulating factor; GR, glutathione reductase; GSH, reduced glutathione; GSSG, oxidized glutathione; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; IFN-γ, interferon-gamma; IL, interleukin; LDL, low-density lipoprotein; MCP-1, monocyte chemoattractant protein-1; MDA, malondialdehyde; MIP-1α, macrophage inflammatory protein-1 alpha; NA, not available; NOS, nitric oxide synthase; OPG, osteoprotegerin; OSI, oxidative stress index; PAI-1, plasminogen activator inhibitor-1; RAGE, receptor for advanced glycation end products; RANKL, receptor activator of nuclear factor-kappa B ligand; ROM, reactive oxygen metabolites; RORC2, RAR-related orphan receptor C2; SCF, stem cell factor; SMAC, second mitochondria-derived activator of caspase; SMD, standardized mean difference; SOD, superoxide dismutase; TAOC, total antioxidant capacity; TC, total cholesterol; TG, triglycerides; TGF-β, transforming growth factor-beta; TIMP, tissue inhibitor of metalloproteinase; TLR, toll-like receptor; TNF-α, tumor necrosis factor-alpha; TOS, total oxidant status; UA, uric acid; VLDL, very low-density lipoprotein; 25(OH)D, 25-hydroxyvitamin D.

Source: Study characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Biomarkers for differentiating diabetic periodontitis from chronic periodontitis: a systematic review and meta-analysis

Source: Article title.

Biomarkers for differentiating diabetic periodontitis from chronic periodontitis: a systematic review and meta-analysis

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Biomarkers for differentiating diabetic periodontitis from chronic periodontitis: a systematic review and meta-analysis

Systematic review · Frontiers in Immunology · 2026

Original publication title

Biomarkers for differentiating diabetic periodontitis from chronic periodontitis: a systematic review and meta-analysis

Li Zhang; Ru Li; Shengnan Zhang; Wenhui Kong; Peipei Zhang; Wenyue Zhang; Jing Sun

Copyright © 2026 Zhang, Li, Zhang, Kong, Zhang, Zhang and Sun.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Significant differences in biomarkers related to lipid metabolism, inflammatory response, and oxidative stress were observed between patients with DMCP and CP. Key indicators demonstrating relatively robust differences include VLDL, 4-HNE, CAT, GSSG, NOS, IL-8, hs-CRP, and C-peptide.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Diabetes-related periodontitis (DMCP) and chronic periodontitis (CP) are associated with significant differences in clinical presentation, pathogenesis, and treatment outcomes. However, reliable biomarkers for their early differentiation remain elusive. This study aims to identify discriminatory biomarkers between DMCP and CP to provide an evidence-based foundation for improved clinical management.

Source: Background

Abstract: What methods does the paper describe?

A systematic search of PubMed, Embase, the Cochrane Library, and Web of Science was conducted from their inception until October 2025 for studies comparing biomarkers in DMCP and CP. Differences in biomarker levels between the two groups were expressed as Standardized Mean Differences (SMD) with 95% Confidence Intervals (CI). All meta-analyses were performed using a random-effects model.

Source: Methods

Abstract: Systematic Review Registration

Abstract: Results

A total of 33 eligible studies were included, involving 970 patients with DMCP and 905 with CP. The meta-analysis revealed the following: (1) lipid profiles: the DMCP group demonstrated significantly higher levels of very low-density lipoprotein (VLDL) (SMD: 0.91; 95%CI: 0.43 to 1.39; P<0.001) compared to the CP group; (2) inflammatory factors: levels of interleukin-8 (IL-8) (SMD: 0.38, 95%CI: 0.06 to 0.70; P=0.021), and high-sensitivity C-reactive protein (hs-CRP) (SMD: 2.56; 95%CI: 0.31 to 4.82; P=0.026) were significantly elevated in the DMCP group; (3) oxidative stress-related markers: A significant decrease was observed in catalase (CAT) (SMD: -0.31; 95%CI: -0.58 to -0.05; P=0.021) and oxidized glutathione (GSSG) (SMD: -1.16; 95%CI: -1.76 to -0.55; P < 0.001) in the DMCP group.

Conversely, levels of nitric oxide synthase (NOS) (SMD: 0.58; 95%CI: 0.11 to 1.05; P=.016) and 4-hydroxynonenal (4-HNE) (SMD: 7.05; 95%CI: 5.07 to 9.03; P < 0.001) were markedly higher; and (4) other biomarkers: the DMCP group exhibited significantly elevated levels of body mass index, eotaxin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and plasminogen activator inhibitor-1, alongside significantly reduced levels of C-peptide and 25-hydroxyvitamin D.

Source: Results

Abstract: Conclusions

Significant differences in biomarkers related to lipid metabolism, inflammatory response, and oxidative stress were observed between patients with DMCP and CP. Key indicators demonstrating relatively robust differences include VLDL, 4-HNE, CAT, GSSG, NOS, IL-8, hs-CRP, and C-peptide.

Source: Conclusions
Authors’ abstract

Background

Diabetes-related periodontitis (DMCP) and chronic periodontitis (CP) are associated with significant differences in clinical presentation, pathogenesis, and treatment outcomes. However, reliable biomarkers for their early differentiation remain elusive. This study aims to identify discriminatory biomarkers between DMCP and CP to provide an evidence-based foundation for improved clinical management.

Methods

A systematic search of PubMed, Embase, the Cochrane Library, and Web of Science was conducted from their inception until October 2025 for studies comparing biomarkers in DMCP and CP. Differences in biomarker levels between the two groups were expressed as Standardized Mean Differences (SMD) with 95% Confidence Intervals (CI). All meta-analyses were performed using a random-effects model.

Results

A total of 33 eligible studies were included, involving 970 patients with DMCP and 905 with CP. The meta-analysis revealed the following: (1) lipid profiles: the DMCP group demonstrated significantly higher levels of very low-density lipoprotein (VLDL) (SMD: 0.91; 95%CI: 0.43 to 1.39; P<0.001) compared to the CP group; (2) inflammatory factors: levels of interleukin-8 (IL-8) (SMD: 0.38, 95%CI: 0.06 to 0.70; P=0.021), and high-sensitivity C-reactive protein (hs-CRP) (SMD: 2.56; 95%CI: 0.31 to 4.82; P=0.026) were significantly elevated in the DMCP group; (3) oxidative stress-related markers: A significant decrease was observed in catalase (CAT) (SMD: -0.31; 95%CI: -0.58 to -0.05; P=0.021) and oxidized glutathione (GSSG) (SMD: -1.16; 95%CI: -1.76 to -0.55; P < 0.001) in the DMCP group.

Conversely, levels of nitric oxide synthase (NOS) (SMD: 0.58; 95%CI: 0.11 to 1.05; P=.016) and 4-hydroxynonenal (4-HNE) (SMD: 7.05; 95%CI: 5.07 to 9.03; P < 0.001) were markedly higher; and (4) other biomarkers: the DMCP group exhibited significantly elevated levels of body mass index, eotaxin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and plasminogen activator inhibitor-1, alongside significantly reduced levels of C-peptide and 25-hydroxyvitamin D.

Conclusions

Significant differences in biomarkers related to lipid metabolism, inflammatory response, and oxidative stress were observed between patients with DMCP and CP. Key indicators demonstrating relatively robust differences include VLDL, 4-HNE, CAT, GSSG, NOS, IL-8, hs-CRP, and C-peptide.

Systematic Review Registration

https://inplasy.com/inplasy-2025-11-0067/, identifier INPLASY2025110067.

Publication and source details

Original title: Biomarkers for differentiating diabetic periodontitis from chronic periodontitis: a systematic review and meta-analysis

Li Zhang; Ru Li; Shengnan Zhang; Wenhui Kong; Peipei Zhang; Wenyue Zhang; Jing Sun

Frontiers in Immunology · 2026

* Correspondence: Jing Sun, sunjing20250909@163.com

†These authors have contributed equally to this work

Copyright © 2026 Zhang, Li, Zhang, Kong, Zhang, Zhang and Sun.2026Zhang, Li, Zhang, Kong, Zhang, Zhang and Sunhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declare that financial support was received for this work and/or its publication. This work was supported by the Science and Technology Development Program of Jinan Municipal Health Commission (No. 2023-2-161) and the Clinical Medicine Science and Technology Innovation Plan of Jinan (Nos. 202328023, 202512030).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:20:05.652407+00:00

DOI: 10.3389/fimmu.2026.1758079 · PMC13290632